Biocryst Pharmaceuticals (BCRX) Return on Capital Employed Growth (1y) (2012 - 2026)
Biocryst Pharmaceuticals (BCRX) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 1,195.00 |
| 10 | Biocryst Pharmaceuticals | 2.35 Bn | 2.28 Bn | 151.04 Mn | -13,939.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,939.00 |
| Dec 31, 2025 | 12,074.00 |
| Sep 30, 2025 | 4,149.00 |
| Jun 30, 2025 | 3,628.00 |
| Mar 31, 2025 | 3,371.00 |
| Dec 31, 2024 | 2,726.00 |
| Sep 30, 2024 | 1,224.00 |
| Jun 30, 2024 | 879.00 |
| Mar 31, 2024 | 443.00 |
| Dec 31, 2023 | 504.00 |
| Sep 30, 2023 | 943.00 |
| Jun 30, 2023 | 1,634.00 |
| Mar 31, 2023 | 843.00 |
| Dec 31, 2022 | 2,191.00 |
| Sep 30, 2022 | 9,496.00 |
| Jun 30, 2022 | 6,382.00 |
| Mar 31, 2022 | 5,189.00 |
| Dec 31, 2021 | 6,167.00 |
| Mar 31, 2021 | 8,684.00 |
| Dec 31, 2020 | 12,858.00 |